• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » UPDATE: Medtronic explores options in $10M patent infringement loss | Legal News

UPDATE: Medtronic explores options in $10M patent infringement loss | Legal News

January 30, 2012 By MassDevice staff

Medtronic EBU guiding catheter

A Medtronic EBU guiding catheter

Medtronic Inc. (NYSE:MDT) is exploring its options regarding a patent infringement loss decided by a jury this week.

An Oklahoma jury ordered Medtronic to pay $9.9 million in back royalties for willfully infringing on a guidance catheter patent owned by Dr. Jan Voda.

"We respectfully disagree with the jury verdict and continue to maintain that our guide catheters do not infringe the Voda patent asserted in this district court case," Medtronic spokeswoman Wendy Dougherty told MassDevice via email. "We are exploring all of our currently available options, which include appeal to the U.S. Court of Appeals for the Federal Circuit."

Voda invented new guiding catheters for delivering balloon devices and stents in the early 1990s and won patents in 2000, according to court documents.

Medtronic’s EBU guiding catheters, Voda argued, infringe existing patents. The Fridley, Minn.-based med-tech titan continued to sell and promote the EBU line after Voda informed them of the infringement, according to the documents.

A jury in the U.S. District Court for Western Oklahoma ruled that Voda’s patents are valid Medtronic and Medtronic Vascular’s infringement was willful.

Medtronic is not the only med-tech titan Voda’s sued for infringement, according to court documents. In 2003, he successfully sued Johnson & Johnson (NYSE:JNJ) subsidiary Cordis Corp. for infringement of the same guiding catheter patents. Voda won again when Cordis took the case to the U.S. Court of Appeal for the Federal Circuit.

gavel

Read more medical device legal news from MassDevice.com

 Convicted former McKesson chairman asks Supreme Court to overturn guilty verdict

Former McKesson Corp. (NYSE:MCK) chairman Charles McCall, convicted of securities fraud in 2009, asked the U.S. Supreme Court to throw out the verdict against him. A lower court judge inappropriately asked the jury to consider whether he "recklessly disregarded" warnings of accounting misdeeds at the company, McCall argued.

McCall was convicted in federal court of 5 counts of securities fraud and circumventing accounting rules in a scheme that cost investors $8.6 billion dollars in the late 1990s. He and McKesson general counsel Jay Lapine were accused of hiding backdated sales contracts from auditors, as well as other activities that artificially inflated the company’s revenue figures, Bloomberg reported.

McCall was sentenced to 10 years in federal prison and fined $1 million.

The recent moves follow McCall’s failed attempts to get his verdict overturned through the 9th Circuit Court of Appeals. Read more

Filed Under: Legal News, News Well, Patent Infringement Tagged With: Cordis Corp., Johnson and Johnson, Legal Roundup, McKesson Corp.

More recent news

  • Neuronetics names Steven Pfanstiel chief financial officer
  • Medtronic to distribute Future Medical’s peripheral guidewires
  • AtriCure completes enrollment in stroke prevention trial
  • GT Medical raises $53M to support brain tumor treatment
  • Imperative Care, Proximie partner to develop surgical robot to treat stroke

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy